![Gene Im Profile](https://pbs.twimg.com/profile_images/1156646723139375104/4DRxLteO_x96.jpg)
Gene Im
@geneyim
Followers
1K
Following
2K
Statuses
618
Transplant Hepatologist @mountsinailiver & @mountsinairmti. Alcohol liver disease, alcohol hepatitis, liver transplantation. #livertwitter
New York City
Joined August 2011
@mezzacappa_c @AshleySpannMD @AGA_CGH @nadimmahmud @serperm @OchoaAllemantMD @docbinujohn @KaplanDeLiver Looking forward to reading this. Time, alcohol use fluctuations and fibrosis are uncertainties in the current MetALD nomenclature and problematic. Low HDL is an independent marker of cirrhosis so that criterion should probably be excluded in advanced fibrosis
0
0
3
ALD-ALLY was years-in-the-making and was inspired by my good friend @AnjanaPillaiMD and her excellent conference @HCCLIVEConf
0
0
2
@scottisaacsmd This adds to the growing evidence of this effect. I would have liked to see confirmation of drinking change with PEth levels over time.
0
0
4
Huge news highlighting the risk of alcohol use with cancer risk
NEW: Today, I’m releasing a Surgeon General’s Advisory on the causal link between alcohol consumption and increased cancer risk. Alcohol is the 3rd leading preventable cause of cancer in the U.S., contributing to about 100,000 cancer cases and 20,000 cancer deaths each year.
0
1
8
RT @CLDFoundation: Join us as international experts drive multidisciplinary discussions to advance the science and care of patients with al…
0
3
0
Check out our new Letter in @JHepatology "The HDL criterion for MetALD can misclassify patients with cirrhosis" w @smruti_rath_med @BibireddyA Re: a great study on impact of # of cardiometabolic RF in MASLD & MetALD by @Dmarti_aguado @rabataller et al.
0
5
20
@DebbieShawcros1 @ebtapper @AmerGastroAssn @MarkThursz @EwanForrest1 Steroid-fan here. STOPAH was a monster landmark trial, but still had issues: no biopsy, terminated early. This individual data meta-analy incl STOPAH of 11 trials showed 28d benefit Probably best used in younger, hepatomegaly, non-F4, non-ACLF>2.
1
0
4
We need to increase reimbursement for screening and treating AUD to reduce the burden of AUD and ALD!
Confused about how to bill for AUD services? This factsheet provides information on billing codes and reimbursement options for screening and treating Alcohol Use Disorder (AUD) in healthcare settings. Check it out on #medicare #medicaid #healthinsurance
0
2
13
@AleksanderKrag @NatRevGastroHep @IsraelsenMads @scottisaacsmd @marurinella @juanpabloarab @rabataller @ebtapper @MajaThiele @NoureddinMD Maybe it's just the alcohol
0
0
3
What a great group! I've been fortunate to work with 4/5 of these bright residents @DOMSinaiNYC during their @MountsinaiRMTI liver rotations and so pleased that are continuing their training with us.
We’re incredibly excited to welcome our newest class of GI fellows! Welcome to the Sinai GI family! @MountSinaiGI @MSHS_IBDCenter @CACTESinai @DOMSinaiNYC
@SatishNagulaMD @BhavanaBRaoMD @brownbrij76
1
0
18
RT @juanpabloarab: Hello #LiverTwitter #LiverX! If you are interested in #ALD and #MetALD, you can not miss these two awesome meetings! 1.…
0
16
0
RT @HEP_Journal: Now Online! Hepatology Special issue on alcohol-associated liver disease. #LiverX
0
13
0
@LuisAntonioDiaz @juanpabloarab @VCU @VCU_Liver @MarcoArreseMD @ArunJSanyalVCU @AASLDtweets Hey that’s me! 😆
0
0
4
Practice-changing results presented by Parissa Tabrizian #TLM2024 Plenary on prospective, multi center study showing remarkably successful downstaging of #HCC with immunotherapy, good outcomes after LT when eligible and low rates of rejection (15%). @MountsinaiRMTI
0
8
33